Transgenic mice reveal roles for TGFα and EGF receptor in mammary gland development and neoplasia

作者: Joyce A. Schroeder , David C. Lee

DOI: 10.1023/A:1026347629876

关键词:

摘要: Transforming growth factor-alpha (TGFα)4 and/or the EGF receptor (EGFR) are frequently overexpressed by human and rodent breast tumors, as well tumor-derived cell lines. Additionally, various observations suggest a role for TGFα EGFR signaling system in normal mouse mammary gland development. Recently, several laboratories have established transgenic mice with which to study of this factor neoplastic biology. Examination these revealed that overexpression has profound consequences tissue. Most strikingly, expressing under control tissue-specific nonspecific promoters stochastically developed focal tumors an incidence latency was markedly affected pregnancy. TGFα-induced were well-differentiated adenomas/adenocarcinomas, although some undifferentiated locally invasive. Distant metastases only occasionally observed. Administration genotoxic carcinogen, 7,12-dimethylbenzanthracene (DMBA), dramatically accelerated tumorigenesis induced transgene, raising possibility acts promoter Mice harboring dual transgenes encoding either wild-type ERBB2 or c-myc displayed compared carrying any single alone, indicative potent cooperativity. Moreover, bitransgenic less dependent on pregnancy, generally more malignant appearance. Finally, also dynamics. consistently precocious alveolar development, variably impaired respect lactation, showed reduced postlactional involution. As result, glands multiparous females accumulated hyperplastic lesions resembled milk-producing alveoli. Limited data support hypothesis precursors tumors. In summary, findings underscore potential importance cellular differentiation transformation gland. They establish powerful model molecules dynamic

参考文章(63)
E. Verhoeven, R. J. A. M. Michalides, W. J. Mooi, E. Schuuring, Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. ,vol. 7, pp. 355- 361 ,(1992)
Brammar Wj, Walker Ra, Varley Jm, Whittaker Jl, Swallow Je, Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. ,vol. 1, pp. 423- 430 ,(1987)
C. Jhappan, G. Merlino, R. Sharp, G. H. Smith, E. C. Kordon, Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. American Journal of Pathology. ,vol. 147, pp. 1081- 1096 ,(1995)
G Merlino, RB Dickson, GH Smith, LT Amundadottir, Johnson, Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth & Differentiation. ,vol. 6, pp. 737- 748 ,(1995)
Alan Robinson, Dickson Rb, Genes, oncogenes, and hormones : advances in cellular and molecular biology of breast cancer Kluwar Academic Publishers. ,(1991)
B. L. M. Hogan, R. Graves-Deal, Y. Matsui, R. J. Coffey, P. Dempsey, S. A. Halter, M. K. Stokes, Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations. American Journal of Pathology. ,vol. 140, pp. 1131- 1146 ,(1992)
J. W. Grisham, D. C. Lee, Ming-Sound Tsao, L. W. Lee, V. W. Raymond, H. S. Earp, Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor α genes in chemically transformed rat liver epithelial cells Cancer Research. ,vol. 51, pp. 5238- 5244 ,(1991)
Vincent F. Vellucci, Zhao-ling Zhou, Ellen B. Stash, Michael Reiss, Activation of the Autocrine Transforming Growth Factor α Pathway in Human Squamous Carcinoma Cells Cancer Research. ,vol. 51, pp. 6254- 6262 ,(1991)
Robert P. C. Shiu, Thomas C. Dembinski, Don Dubik, Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Research. ,vol. 47, pp. 6517- 6521 ,(1987)